Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.
Focal Therapy for Prostate Cancer Advances Read More »
By R. Morgan Griffin Reviewed By Varnada Karriem-Norwood, MD Have you given up on exercise? A lot of older people do — just one out of four people between the ages of 65 and 74 exercises regularly. Many people assume that they’re too out-of-shape, or sick, or tired, or just plain old to exercise. They’re wrong. Read the article.
Myths About Exercise and Older Adults Read More »
To read the full newsletter please click here: Awareness: The “PCCN-Toronto” and “Side by Side” Prostate Cancer Support Groups Newsletter March 2013 (pdf) In this issue: Dr. Laurence Klotz / New member of the board / Bill Sceviour steps down / Dr. Keith Jarvi – March 27th / North York Harvest Food Bank / Thank you to Scotiabank / 2013 Conference Postponed / Our Voice magazine / Volunteers are needed / Meet John Roth / PCC’s new President & CEO / PCC’s New Advisory Council / Walk/Run Instructions / PCCN-Toronto Word Search / On-going Projects for 2013 / PCCN-Toronto Board
Halving the time a patient with high-risk prostate cancer (PCa) is on androgen deprivation therapy (ADT) is safe and does not compromise outcomes, researchers concluded. Read the article, which includes a short video.
ADT Duration for Prostate Cancer Can Be Cut in Half Read More »
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. Focal laser ablation uses precisely targeted heat, delivered through a small insertion and guided into the prostate by magnetic resonance imaging, to burn away cancerous cells in the prostate. Read the article.
Focal Therapy Offers Middle Ground for Some Prostate Cancer Patients Read More »
Groundbreaking research by a team of UCLA physicians and engineers demonstrates that prostate cancer — long identifiable only through painful, hit-or-miss biopsies — can be diagnosed far more easily and accurately using a new image-guided, targeted biopsy procedure. Read the article, which includes a video.
Prostate cancer now detectable using imaging-guided biopsy Read More »
January 2013 Scotiabank Awateness Night Dr.Laurence Klotz, MD, FRCSC Professor, Department of Surgery, University of Toronto Chief, Division of Urology, Sunnybrook Health Sciences Centre Chair, Canadian Uro-Oncology Group and NCIC GU Site Group Editor in Chief (founding), Canadian Journal of Urology Chair, Global GU Oncology Group For localized prostate cancer, the choice of treatment is becoming less straightforward as preferences shift to less aggressive, less intrusive, and increasingly sophisticated approaches. This presentation provides guidance and insight…with focus on active surveillance, focal therapy, MRI imaging, and recent developments in surgery. CLICK ON THE ARROW TO START THE VIDEO “Navigating treatment
VIDEO: Dr. Laurence Klotz, “Navigating treatment options for localized prostate cancer” Read More »
Men with early-stage prostate cancer may be able to inhibit tumor growth and progression by following a high-fiber diet, according to recent study results. Read the article.
Diet can thwart prostate cancer progression Read More »
New findings add to mounting evidence suggesting that tea consumption may lower the risk of developing prostate cancer. The findings are based on a population-based case-control study conducted in King County, Washington. The study, by Milan S. Geybels, MSc, of the Department of Epidemiology, Maastricht University, Maastricht, The Netherlands, and colleagues examined associations between PCa risk and tea and coffee consumption. The tea-related analysis focused on 863 PCa cases and 863 controls; the coffee-related analysis included 894 cases and 860 controls. Read the article.
Tea May Lower Prostate Cancer Risk Read More »
Evan Y. Yu, MD describes his clinical approach to the treatment patients with bone metastases secondary to prostate cancer. View this video.
Optimizing Therapeutic Strategies Targeting Bone: Prostate Cancer Read More »